Ann Hirschman, APN Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 88 Orchard Rd Ste 2-1, Skillman, NJ 08558 Phone: 609-468-6242 |
News Archive
Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, announced the National Cancer Institute (NCI) will sponsor a multi-center phase 2 study of Syndax's lead product entinostat, a novel inhibitor of histone deacetylases (HDAC), and anastrozole, an aromatase inhibitor, in postmenopausal women with operable triple negative breast cancer to evaluate biomarkers and surrogates for response.
Scientists have identified key molecules that mediate radioresistance in glioblastoma multiforme; these molecules are a potential target for the treatment of this brain cancer.
The Accreditation Council for Graduate Medical Education will honor Christian de Virgilio, MD, a principal investigator at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), with its Parker J. Palmer Courage to Teach Award for Program Director Excellence at its 2011 awards ceremony in Nashville, Tenn.
Cell Therapeutics, Inc. today announced the closing of its previously announced sale of 15,000 shares of its Series 18 Preferred Stock directly to Quogue Capital LLC and an affiliate of Perceptive Advisors LLC in a registered direct offering conducted without an underwriter or placement agent for gross proceeds of approximately $15 million (the "Offering").
› Verified 1 days ago